首页|期刊导航|广州中医药大学学报|基于血清代谢组学的阻塞性睡眠呼吸暂停中医证型代谢模式差异分析

基于血清代谢组学的阻塞性睡眠呼吸暂停中医证型代谢模式差异分析OA

Differential Analysis of Metabolic Patterns in Traditional Chinese Medicine Syndrome Types of Obstructive Sleep Apnea Based on Serum Metabolomics

中文摘要英文摘要

[目的]阻塞性睡眠呼吸暂停(OSA)是一种常见的睡眠障碍性疾病,中医"三焦气化不利"理论是阐释其病机的重要学说,但该理论的现代生物学基础,特别是在分子层面的阐释尚不充分.本研究旨在通过血清代谢组学技术,揭示OSA不同中医证型的差异性代谢模式,从分子角度为"三焦气化不利"理论提供科学依据.[方法]招募2024年6月至2025年5月在喀什地区第一人民医院中医科病房或门诊就诊的OSA患者共57例(其中肺脾虚证22例、痰湿证21例、血瘀证14例),以及同期年龄、性别相匹配的来自喀什地区第一人民医院体检中心的22例健康志愿者(健康对照组).采集血清样本,采用超高效液相色谱-质谱联用(UPLC-MS)技术进行非靶向代谢组学检测.利用正交偏最小二乘法判别分析(OPLS-DA)筛选组间差异性代谢物,并通过受试者工作特征(ROC)曲线评估潜在生物标志物的诊断效能.同时,对差异代谢物进行代谢通路富集分析.[结果]OPLS-DA模型能清晰区分OSA各证型组与健康对照组.共筛选出大量差异性代谢物,其中肺脾虚证、痰湿证、血瘀证分别与健康对组照比较,各筛选出241、189和61个显著差异代谢物.各证型拥有特征性的潜在生物标志物组合.代谢通路分析显示,肺脾虚证差异代谢物主要富集于谷胱甘肽代谢、FoxO信号通路等;痰湿证主要富集于嘌呤代谢、丙氨酸、天冬氨酸与谷氨酸代谢等;血瘀证则主要富集于酪氨酸代谢、抗坏血酸与醛糖酸代谢等通路.[结论]首次从代谢组学层面系统揭示了OSA不同中医证型存在特异性的代谢紊乱谱,从分子层面直观地印证了OSA核心病机为"三焦气化不利"及其病机由"上焦-中焦功能失调"向"络脉瘀阻"演变的科学内涵.

Objective Obstructive sleep apnea(OSA)is a common sleep-related breathing disorder.The theory of"dysfunction of qi transformation in the triple-energizer"in traditional Chinese medicine(TCM)is one kind of important theory for elucidating its pathogenesis.However,the modern biological basis of this theory,particularly its molecular-level interpretation,remains insufficiently explored.This study aims to reveal the differential metabolic patterns associated with different TCM syndrome types in OSA using serum metabolomics,thereby providing a scientific basis for the"dysfunction of qi transformation in the triple-energizer"theory from a molecular perspective.Methods A total of 57 OSA patients(22 with lung-spleen deficiency syndrome,21 with phlegm-damp syndrome,and 14 with blood stasis syndrome)who visited the inpatient ward or outpatient clinic of the Department of Traditional Chinese Medicine at the First People's Hospital of Kashi Prefecture from June 2024 to May 2025 were recruited.Additionally,22 age-and gender-matched healthy volunteers from the Physical Examination Center of the same hospital during the same period were enrolled as the healthy control group.Serum samples were collected from all participants.Untargeted metabolomic profiling was performed using ultra-performance liquid chromatography-mass spectrometry(UPLC-MS).Orthogonal partial least squares discriminant analysis(OPLS-DA)was employed to screen for differential metabolites between groups.Receiver operating characteristic(ROC)curve analysis was used to evaluate the diagnostic efficacy of potential biomarkers.Metabolic pathway enrichment analysis was conducted for the identified differential metabolites.Results OPLS-DA models clearly distinguished each OSA syndrome type group from the healthy control group.A substantial number of differential metabolites were identified.Compared with the healthy control group,241,189,and 61 significantly differential metabolites were screened in the lung-spleen deficiency syndrome,phlegm-damp syndrome,and blood stasis syndrome groups,respectively.Each syndrome type possessed characteristic combinations of potential biomarkers.Metabolic pathway analysis revealed that differential metabolites in the lung-spleen deficiency syndrome were primarily enriched in glutathione metabolism and the FoxO signaling pathway.Differential metabolites in the phlegm-damp syndrome were mainly enriched in purine metabolism and alanine,aspartate,and glutamate metabolism.Differential metabolites in the blood stasis syndrome were predominantly enriched in tyrosine metabolism and ascorbate and aldarate metabolism.Conclusion This study systematically reveals,for the first time from a metabolomic perspective,the existence of specific metabolic disorder profiles associated with different TCM syndrome types of OSA.The results provide molecular-level evidence intuitively corroborating the scientific connotation of OSA pathogenesis evolving along the"dysfunction of qi transformation in the triple-energizer"theory,and its transitions from"upper-and middle-energizer dysfunction"to"collateral stasis obstruction".

吴苑;李际强;黄颖;姜小秋;黄祺;侯旭阳;彭欧阳;谭钊琦;排孜拉·帕尔哈提;余芳;陈剑坤;蔡倩

广州中医药大学第二附属医院(广东省中医院),广东 广州 510120广州中医药大学第二附属医院(广东省中医院),广东 广州 510120广州中医药大学第二附属医院(广东省中医院),广东 广州 510120喀什地区第一人民医院,新疆 喀什 844000南京中医药大学第三临床医学院,江苏 南京 210000广州中医药大学第二临床医学院,广东 广州 510405广州中医药大学第二临床医学院,广东 广州 510405广州中医药大学第二临床医学院,广东 广州 510405喀什地区第一人民医院,新疆 喀什 844000广州中医药大学第二附属医院(广东省中医院),广东 广州 510120广州中医药大学第二附属医院(广东省中医院),广东 广州 510120广州中医药大学第二附属医院(广东省中医院),广东 广州 510120

医药卫生

阻塞性睡眠呼吸暂停代谢组学差异性代谢物代谢通路潜在生物标志物三焦气化中医证型痰湿证肺脾虚证血瘀证上焦-中焦功能失调络脉瘀阻

《广州中医药大学学报》 2026 (6)

1431-1441,11

省部共建中医湿证国家重点实验室喀什工作站联合资金项目(编号:SZGZZ20240047)广东省援疆农村科技(特派员)项目(编号:KTPYJ2024011)广东省中医院优秀中医临床人才研修项目(编号:中医二院[2024]88号)广东省中医院成果转化孵化专项(编号:ZH2025ZJYF04)

10.13359/j.cnki.gzxbtcm.2026.06.002

评论